Target intelligence / Profile preview

Cys2His2 zinc finger DNA-binding domain (C2H2-ZNF)

Target
C2H2-ZNF
Molecular classification
Transcription factor, DNA-binding protein, Zinc finger protein family
01

Overview

The Cys2His2 (C2H2) zinc finger DNA-binding domain is the most common DNA-binding motif found in eukaryotic transcription factors, characterized by a consensus sequence where a zinc ion is coordinated by two cysteine and two histidine residues (UniProt: PRO_0000044506). These domains typically consist of an alpha-helix and a two-stranded beta-sheet, where the alpha-helix inserts into the major groove of the DNA to recognize specific nucleotide triplets (PubMed: 15718139). Beyond DNA binding, C2H2 domains can also mediate RNA binding and protein-protein interactions, making them versatile regulators of gene expression and cellular signaling (PubMed: 23395138). In therapeutic contexts, C2H2 domains have been extensively engineered to create Zinc Finger Nucleases (ZFNs) for precision genome editing and artificial transcription factors for gene modulation (PubMed: 20871606). Dysregulation or mutation of proteins containing these domains is linked to various pathologies, including oncogenesis, where they may act as either activators or repressors of tumor-related genes (PubMed: 28231538). While highly specific, the primary challenge in targeting or utilizing these domains remains the risk of off-target effects and the complexity of designing domains for non-canonical DNA sequences.

Other names
C2H2 zinc fingerKrüppel-type zinc fingerClassical zinc fingerZinc finger C2H2-typeCys2-His2 zinc finger
02

Mechanism of action

Engineered C2H2-ZNF domains are used in Zinc Finger Nucleases (ZFNs) to induce site-specific double-strand breaks for gene editing (PubMed: 20871606). Small molecules can also disrupt the coordination of the zinc ion or compete for DNA binding sites (PubMed: 15575857).

03

Biological functions

DNA bindingRNA bindingProtein-protein interactionTranscriptional regulationChromatin remodelingGene expression control
04

Disease associations

CancerNeurodevelopmental disordersDiabetesViral infectionInflammation
05

Safety considerations

Off-target DNA binding and cleavageImmunogenicity of engineered proteinsDisruption of essential endogenous transcription factorsPotential for insertional mutagenesis in gene therapy
06

Interacting drugs

Zinc finger nucleases (ZFNs)

4 more in the full profile.

07

Biomarkers

ZNF protein expression levelsDNA methylation patterns at ZNF binding sitesZinc finger protein mutations

Beyond the preview

Go deeper on Cys2His2 zinc finger DNA-binding domain (C2H2-ZNF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cys2His2 zinc finger DNA-binding domain (C2H2-ZNF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call